
Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8948 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Pemetrexed Sodium 1-Methyl Ester ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H22N5O6·NaColor and Shape:White Off-White SolidMolecular weight:440.15701Theophylline
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormula:C7H8N4O2Color and Shape:White PowderMolecular weight:180.17 g/molFebuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C14H12N2O3SColor and Shape:Off-White Fine PowderMolecular weight:288.05686Pemetrexed Glutamide Sodium ((S)-4-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanamido)-4-carboxybutanoate, sodium salt)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C25H27N6O9·NaColor and Shape:Blue SolidMolecular weight:555.18395Caffeine Related Compound D (3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormula:C7H8N4O2Color and Shape:White Crystalline PowderMolecular weight:180.06473Clopidogrel-β-D-glucuronide ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H22ClNO8SColor and Shape:White Off-White SolidMolecular weight:483.07547Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C15H14N2O3SColor and Shape:White Fine PowderMolecular weight:302.07251Pemetrexed Disodium (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C20H19N5Na2O6·7H2OColor and Shape:White PowderMolecular weight:597.18702Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Clopidogrel Open Ring Methyl Ester Hydrochloride (methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H16ClNO2SHClColor and Shape:White Off-White SolidMolecular weight:346.282-Oxo Clopidogrel (Mixture of Diastereomers) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:Off-White SolidMolecular weight:337.05394Caffeine Related Compound C (1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C8H10N4O2Color and Shape:White Fine PowderMolecular weight:194.080382-Oxo R-Clopidogrel (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:White Off-White SolidMolecular weight:337.05394Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C14H13NOColor and Shape:White Off-White PowderMolecular weight:211.09971Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Ondansetron
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C18H19N3OColor and Shape:White Off-White PowderMolecular weight:293.15281Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H13ClNO2S·ClColor and Shape:Off-White SolidMolecular weight:318.03555(R)-Clopidogrel Carboxylic Acid ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H14ClNO2SColor and Shape:Off-White SolidMolecular weight:307.04338Caffeine Related Compound F (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C7H8N4O2Color and Shape:White Fine PowderMolecular weight:180.06473Acetaminophen
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C8H9NO2Color and Shape:White PowderMolecular weight:151.06333

